Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.03
-0.01 (-0.10%)
Feb 28, 2025, 4:00 PM EST - Market closed
TDAC Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -0.55 | -0.49 | -0.07 |
| Other Amortization | 0.48 | 0.48 | - |
| Change in Other Net Operating Assets | 0.02 | 0 | -0.08 |
| Operating Cash Flow | -0.04 | -0 | -0.15 |
| Total Debt Issued | 0.27 | - | 0.34 |
| Net Debt Issued (Repaid) | 0.27 | - | 0.34 |
| Issuance of Common Stock | - | - | 0.04 |
| Other Financing Activities | -0.01 | - | -0.23 |
| Financing Cash Flow | 0.26 | - | 0.15 |
| Net Cash Flow | 0.22 | -0 | 0 |
| Free Cash Flow | -0.04 | -0 | -0.15 |
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.04 |
| Levered Free Cash Flow | - | 0.19 | - |
| Unlevered Free Cash Flow | - | -0.29 | - |
| Change in Net Working Capital | - | -0.01 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.